Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Revance Therapeutics Company Profile (NASDAQ:RVNC)

Consensus Ratings for Revance Therapeutics (NASDAQ:RVNC) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $37.98 (120.17% upside)

Analysts' Ratings History for Revance Therapeutics (NASDAQ:RVNC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/11/2014ZacksDowngradeNeutral$18.90ViewTweet This Rating  Share This Rating on StockTwits
12/9/2014William BlairInitiated CoverageOutperform$35.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014BMO Capital MarketsInitiated CoverageOutperform$37.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Cowen and CompanyInitiated CoverageOutperform$55.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Piper JaffrayInitiated CoverageOverweight$44.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/18/2012 forward)